JO
BPTH

John Overdeck’s Bio-Path Holdings Inc BPTH Stock Holding History

John Overdeck’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,236
Closed -$504K – 3759
2019
Q1 		$504K Buy
+1,236
New +$227K ﹤0.01% 2266

Other funds holding BPTH

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 27.61% 1-Year Est. Return

John Overdeck's BPTH Position: Q2 2019 in Review

John Overdeck sold out of Bio-Path Holdings Inc (BPTH) in Q2 2019, closing a stake of 1,236 shares — an estimated $504K sold.

John Overdeck first reported a position in BPTH in Q1 2019 and held it in 1 quarter. The position peaked at $504K in Q1 2019. 17 funds tracked by Wall St. Rank hold BPTH as of Q2 2019.

  • John Overdeck reported no remaining Bio-Path Holdings Inc position as of Q2 2019 after selling out during the quarter.
  • John Overdeck sold 1,236 Bio-Path Holdings Inc shares in Q2 2019, an estimated $504K.
  • John Overdeck first reported a position in Bio-Path Holdings Inc in Q1 2019 and held it in 1 quarter.
  • John Overdeck's Bio-Path Holdings Inc position peaked at $504K in Q1 2019.
  • 17 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q2 2019.

Based on Two Sigma Investments's 13F filing for Q2 2019, filed 14 Aug 2019.